AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Claglid Met 60mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Proqol Healthcare

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Claglid Met 60mg/500mg Tablet

Metformin/Gliclazide 60mg/500mg tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical guidance risks elevated glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting glucose source (e.g., sugary snacks or juice) to counteract hypoglycemia and maintain regular mealtimes. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are typically recommended.

Uses of Claglid Met 60mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Claglid Met 60mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Claglid Met 60mg/500mg tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

Common Side effects of Claglid Met 60mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Claglid Met 60mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Claglid Met 60mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Claglid Met 60mg/500mg Tablet works:

Gliclazide and Metformin, combined at 60mg/500mg in Claglid Met tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Claglid Met 60mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Claglid Met 60mg/500mg tablets is contraindicated during pregnancy due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Claglid Met 60mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Claglid Met 60mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician. For those with severe kidney disease, Claglid Met 60mg/500mg tablets are contraindicated. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Claglid Met 60mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, initiation should be at a low dosage; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Claglid Met 60mg/500mg Tablet :

Should you forget to take your Claglid Met 60mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Claglid Met 60mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Claglid Met 60mg/500mg Tablet

Claglid Met 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Claglid Met 60mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Claglid Met 60mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Claglid Met 60mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or heavy alcohol consumers. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Claglid Met 60mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Claglid Met 60mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Claglid Met 60mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining alcohol with Claglid Met 60mg/500mg tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Claglid Met 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Claglid Met 60mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Claglid Met 60mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Claglid Met 60mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Claglid Met 60mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Claglid Met 60mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Claglid Met 60mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in individuals with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining alcohol and Claglid Met 60mg/500mg tablets is unsafe. Alcohol can worsen hypoglycemia and raise the risk of lactic acidosis.
Claglid Met 60mg/500mg Ta...
87
MRP 106
18% off